J

Jacobson Pharma Corporation Ltd
HKEX:2633

Watchlist Manager
Jacobson Pharma Corporation Ltd
HKEX:2633
Watchlist
Price: 1.25 HKD 0.81% Market Closed
Market Cap: HK$2.5B

Relative Value

The Relative Value of one Jacobson Pharma Corporation Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 1.25 HKD, Jacobson Pharma Corporation Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Jacobson Pharma Corporation Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Jacobson Pharma Corporation Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
HK
Jacobson Pharma Corporation Ltd
HKEX:2633
2.5B HKD 1.6 8.3 6.2 6.2
US
Eli Lilly and Co
NYSE:LLY
985.1B USD 16.6 53.5 35.9 38.5
US
Johnson & Johnson
NYSE:JNJ
554.2B USD 5.9 20.8 14.5 17.7
CH
Roche Holding AG
SIX:ROG
283.2B CHF 4.6 29.9 12.6 14.8
UK
AstraZeneca PLC
LSE:AZN
214.3B GBP 5.1 31.3 14.9 21.9
CH
Novartis AG
SIX:NOVN
224.7B CHF 5.1 20 12.6 16.2
US
Merck & Co Inc
NYSE:MRK
281.3B USD 4.4 15 10.6 12.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.2 15.9 11 12.8
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
US
Pfizer Inc
NYSE:PFE
150.9B USD 2.3 14.7 7.5 10.2
FR
Sanofi SA
PAR:SAN
97.3B EUR 1.7 8.2 7.6 7.6
P/E Multiple
Earnings Growth PEG
HK
J
Jacobson Pharma Corporation Ltd
HKEX:2633
Average P/E: 21.7
8.3
7%
1.2
US
Eli Lilly and Co
NYSE:LLY
53.5
54%
1
US
Johnson & Johnson
NYSE:JNJ
20.8
6%
3.5
CH
Roche Holding AG
SIX:ROG
29.9
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.3
38%
0.8
CH
Novartis AG
SIX:NOVN
20
17%
1.2
US
Merck & Co Inc
NYSE:MRK
15
14%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
15.9
2%
7.9
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
FR
Sanofi SA
PAR:SAN
8.2
1%
8.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
HK
J
Jacobson Pharma Corporation Ltd
HKEX:2633
Average EV/EBITDA: 42.4
6.2
13%
0.5
US
Eli Lilly and Co
NYSE:LLY
35.9
34%
1.1
US
Johnson & Johnson
NYSE:JNJ
14.5
2%
7.2
CH
Roche Holding AG
SIX:ROG
12.6
5%
2.5
UK
AstraZeneca PLC
LSE:AZN
14.9
10%
1.5
CH
Novartis AG
SIX:NOVN
12.6
6%
2.1
US
Merck & Co Inc
NYSE:MRK
10.6
6%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
11
1%
11
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
FR
Sanofi SA
PAR:SAN
7.6
8%
1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
HK
J
Jacobson Pharma Corporation Ltd
HKEX:2633
Average EV/EBIT: 90.3
6.2
2%
3.1
US
Eli Lilly and Co
NYSE:LLY
38.5
37%
1
US
Johnson & Johnson
NYSE:JNJ
17.7
6%
3
CH
Roche Holding AG
SIX:ROG
14.8
6%
2.5
UK
AstraZeneca PLC
LSE:AZN
21.9
23%
1
CH
Novartis AG
SIX:NOVN
16.2
12%
1.4
US
Merck & Co Inc
NYSE:MRK
12.6
8%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
12.8
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
835.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5
FR
Sanofi SA
PAR:SAN
7.6
6%
1.3